Openly accessible

Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis

Dong, Zhiyong, Islam, Sheikh Mohammed Shariful, Yu, Ashley M., Qu, Rui, Guan, Bingsheng, Zhang, Junchang, Hong, Zhao and Wang, Cunchuang 2018, Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis, BMC surgery, vol. 18, no. 1, doi: 10.1186/s12893-018-0406-3.

Attached Files
Name Description MIMEType Size Downloads
islam-laparoscopicmetabolic-2018.pdf Published version application/pdf 1.01MB 1

Title Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis
Author(s) Dong, Zhiyong
Islam, Sheikh Mohammed SharifulORCID iD for Islam, Sheikh Mohammed Shariful orcid.org/0000-0001-7926-9368
Yu, Ashley M.
Qu, Rui
Guan, Bingsheng
Zhang, Junchang
Hong, Zhao
Wang, Cunchuang
Journal name BMC surgery
Volume number 18
Issue number 1
Article ID 73
Total pages 10
Publisher BioMed Central
Place of publication London, Eng.
Publication date 2018-09-17
ISSN 1471-2482
1471-2482
Keyword(s) BMI < 35 kg/m2, evidence-based analysis
Metabolic surgery
Obesity
Type 2 diabetes
Summary BACKGROUND: Laparoscopic metabolic surgery has been previously shown to be an effective treatment for obese patients with type 2 diabetes (T2DM). The objective of this scoping review is to determine the impact of metabolic surgery for the treatment of type 2 diabetes in Asia and perform an evidence-based analysis.

METHODS: We performed a literature search in PubMed for research on laparoscopic metabolic surgery for the treatment of T2DM in Asia region. We classified the included studies based on the Oxford Center for Evidence Based Medicine guidelines. And performed and evidence analysis.

RESULTS: In total, 205 articles were identified. 62.9% of the studies were from East Asia. The evidence of 26 studies are level I, 59 are level II. Laparoscopic sleeve gastrectomy (LSG) was the most commonly reported surgical procedure (63.1%) in Asia. The number of laparoscopic metabolic surgery for T2DM in Asian countries has increased rapidly over the last 8 years. We identified 16 studies which showed that laparoscopic metabolic surgery is an effective and safe treatment for T2DM in patients with a BMI of > 25 kg/m2 to < 35 kg/m2 in Asia.

CONCLUSIONS: Our results suggest that laparoscopic metabolic surgery might be an effective and safe treatment for T2DM patients with BMI < 35 kg/m2, and that LSG is the most commonly performed surgical procedure for this in Asia.
Language eng
DOI 10.1186/s12893-018-0406-3
Field of Research 1103 Clinical Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2018, The Authors
Free to Read? Yes
Use Rights Creative Commons Attribution licence
Persistent URL http://hdl.handle.net/10536/DRO/DU:30113784

Document type: Journal Article
Collections: School of Exercise and Nutrition Sciences
Open Access Collection
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 6 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Thu, 20 Sep 2018, 08:16:36 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.